340B Report Publisher and CEO Slafsky: Providers Need Swift Action on Contract Pharmacy
340B health care providers are hopeful that U.S. health secretary Xavier Becerra will sanction six drug manufacturers that have either stopped providing 340B discounts or placed restrictions on 340B pricing in the contract pharmacy setting, 340B Report Publisher and CEO Ted Slafsky writes this week in his latest column for Omnicell.